← back to search

Deepak Kanojia

Dr. K.N.Modi University · IN
Area of research
Oncology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Metal complexes synthesis and properties, Radiopharmaceutical Chemistry and Applications, Click Chemistry and Applications, and Cancer Research and Treatments.
h-index
25
citations
2,619
works
165
NIH funding
primary concept
email

Recent publications

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
Nature Communications 2023cited by 46position: middledoi
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma
Clinical Cancer Research 2022cited by 13position: middledoi
BIOM-32. ENDOPLASMIC RETICULUM PROTEIN SSR3 DETERMINES AND PREDICTS RESPONSE TO PACLITAXEL IN BREAST CANCER AND GLIOBLASTOMA
Neuro-Oncology 2021cited by 0position: middledoi
Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model
Oncotarget 2017cited by 68position: middledoi
Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma
Oncotarget 2017cited by 30position: middledoi
Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma
Stem Cell Reports 2016cited by 61position: middledoi
Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters
Journal of Translational Medicine 2016cited by 18position: middledoi
Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma
Journal of Nuclear Medicine 2015cited by 92position: middledoi
Sui generis: gene therapy and delivery systems for the treatment of glioblastoma
Neuro-Oncology 2015cited by 81position: middledoi
βIII-Tubulin Regulates Breast Cancer Metastases to the Brain
Molecular Cancer Therapeutics 2015cited by 55position: firstdoi
Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases
Stem Cells 2015cited by 52position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Maciej S. Lesniak · Northwestern University10 papers (2015–2022)Lingjiao Zhang · Warren County Community College6 papers (2015–2017)Atique U. Ahmed · Northwestern University6 papers (2015–2022)Julius W. Kim · Neurological Surgery5 papers (2015–2017)Irina V. Balyasnikova · Northwestern University4 papers (2015–2016)Karen S. Aboody · City Of Hope National Medical Center4 papers (2015–2016)J. Robert Kane · Northwestern University4 papers (2015–2021)Ramin A. Morshed · University of Tokyo Hospital3 papers (2015–2015)Drew Spencer · Northwestern University3 papers (2015–2016)Jason Miska · Northwestern University3 papers (2015–2016)Dou Yu · Ningbo University3 papers (2015–2016)Jacob S. Young · UCSF Helen Diller Family Comprehensive Cancer Center3 papers (2015–2017)Daniel Y. Zhang · ETH Zurich2 papers (2021–2022)Álex Cordero · Neurological Surgery2 papers (2021–2022)Jiangshan Zhang · Central South University2 papers (2021–2022)Balázs Győrffy · Royal Canadian Navy2 papers (2021–2022)Jian Qiao · Southwestern Medical Center2 papers (2015–2016)Seong Jae Kang · Neurological Surgery2 papers (2021–2022)Víctor A. Arrieta · Northwestern University2 papers (2021–2022)Brandyn Castro · University of Illinois Urbana-Champaign2 papers (2021–2022)